Hosted on MSN1mon
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...
National Institute for Health and Care Excellence1mon
Tirzepatide for managing overweight and obesity
Tirzepatide is recommended as an option for managing overweight ... Use a lower BMI threshold (usually reduced by 2.5 kg/m 2) for people from South Asian, Chinese, other Asian, Middle Eastern, Black ...
Yahoo1mon
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
Tirzepatide, the active ingredient in Zepbound and Mounjaro, is no longer in short supply, the FDA says. Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025 ...
National Institute for Health and Care Excellence1mon
Tirzepatide for managing overweight and obesity
A lower BMI threshold (usually reduced by 2.5 kg/m 2) is used for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds. Tirzepatide may ...